Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Astria Therapeutics, Inc. (ATXS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K/A10-K10-K10-K10-K
Operating activities          
Net loss  -51.8-194.9-37.3-26.3-25.9-27.4-36.1-32.6
   
Reconciliation of net loss to net cash used in operating activities:          
    Stock-based compensation expense  4.63.41.4 1.82.02.21.7
    Other non-cash items  0.10.00.11.6    
    Changes in assets and liabilities:          
        Prepaid expenses and other assets  -1.60.11.3-1.3-0.2-0.1-0.2-0.5
        Lease liability - operating lease  0.6-0.7      
        Accounts payable  -0.8-2.00.3-0.20.7-0.60.10.2
        Accrued expenses  4.4-1.31.6-0.20.4-1.20.41.0
            Net cash used in operating activities  -43.5-30.2-32.5-26.6-23.5-26.8-32.9-29.8
   
Investing activities          
Purchases of short-term investments  -396.1-78.0-62.8-155.2-70.4 -45.5 
Sales and maturities of short-term investments  229.059.069.1151.148.114.930.5 
Purchases of property and equipment  -0.10.00.00.0 -0.1-0.5-0.4
    Net cash provided by (used in) investing activities  -167.1-12.66.3-4.1-21.914.9-15.5-0.4
   
Financing activities          
Proceeds from exercise of stock options  0.10.00.00.10.00.00.50.1
    Net cash provided by financing activities  144.7104.340.925.644.34.79.278.3
   
Supplemental disclosure of non-cash transactions:          
    Conversion of Series X Preferred Stock into common stock   168.9      

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy